KR20110112279A - 의약품 및 치료 - Google Patents

의약품 및 치료 Download PDF

Info

Publication number
KR20110112279A
KR20110112279A KR1020117011015A KR20117011015A KR20110112279A KR 20110112279 A KR20110112279 A KR 20110112279A KR 1020117011015 A KR1020117011015 A KR 1020117011015A KR 20117011015 A KR20117011015 A KR 20117011015A KR 20110112279 A KR20110112279 A KR 20110112279A
Authority
KR
South Korea
Prior art keywords
ibuprofen
paracetamol
medicament
osteoarthritis
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117011015A
Other languages
English (en)
Korean (ko)
Inventor
할틀리 캠프벨 앳킨슨
Original Assignee
에이에프티 파마슈티칼스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20110112279(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에이에프티 파마슈티칼스 리미티드 filed Critical 에이에프티 파마슈티칼스 리미티드
Publication of KR20110112279A publication Critical patent/KR20110112279A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020117011015A 2008-10-14 2009-10-12 의약품 및 치료 Ceased KR20110112279A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
NZ569612 2008-10-14

Publications (1)

Publication Number Publication Date
KR20110112279A true KR20110112279A (ko) 2011-10-12

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117011015A Ceased KR20110112279A (ko) 2008-10-14 2009-10-12 의약품 및 치료

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201102810T2 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1781277T3 (pl) 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
MY160572A (en) 2010-11-04 2017-03-15 Aft Pharmaceuticals Ltd A combination composition
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
JP7152481B2 (ja) * 2017-07-10 2022-10-12 ジェル キャップ テクノロジーズ，エルエルシー 二重放出カプセル剤形、ならびにそれを製造する方法、装置およびシステム
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
PL1781277T3 (pl) * 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
HRP20190891T1 (hr) 2019-07-12
MX2011003928A (es) 2011-08-12
RU2011111792A (ru) 2012-11-27
BRPI0914086A2 (pt) 2020-01-21
EP2341900B1 (en) 2019-02-20
MX340662B (es) 2016-07-20
CH702339B1 (de) 2016-06-15
JP2012505830A (ja) 2012-03-08
CA2735834C (en) 2017-05-16
GB201105249D0 (en) 2011-05-11
PT2341900T (pt) 2019-05-14
SI2341900T1 (sl) 2019-06-28
TR201102810T2 (tr) 2011-05-23
EP2341900A1 (en) 2011-07-13
ES2725151T3 (es) 2019-09-19
AU2009304002B9 (en) 2014-06-26
LT2341900T (lt) 2019-04-10
NZ591496A (en) 2012-12-21
US20110166234A1 (en) 2011-07-07
RU2487707C2 (ru) 2013-07-20
AU2009304002B2 (en) 2013-04-18
ZA201101752B (en) 2012-02-29
CA2735834A1 (en) 2010-04-22
MA32635B1 (fr) 2011-09-01
CO6341553A2 (es) 2011-11-21
GB2476418B (en) 2013-04-24
CN102215835A (zh) 2011-10-12
GB2476418A (en) 2011-06-22
WO2010044681A1 (en) 2010-04-22
CY1122198T1 (el) 2020-11-25
MY153932A (en) 2015-04-15
AU2009304002A1 (en) 2010-04-22
TR201906742T4 (tr) 2019-05-21
EP2341900A4 (en) 2012-02-29
PL2341900T3 (pl) 2019-08-30
CL2011000678A1 (es) 2011-09-23
HUE043063T2 (hu) 2019-07-29
DK2341900T3 (da) 2019-05-20

Similar Documents

Publication Publication Date Title
US6689399B1 (en) Transdermal delivery of an anti-inflammatory composition
JP2019131598A5 (enExample)
Sunshine New clinical experience with tramadol
KR101900520B1 (ko) 복합 조성물
KR20110112279A (ko) 의약품 및 치료
TW201615221A (zh) 炎症用藥臨床新應用
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
KR20090089867A (ko) 간독성 감소를 비롯한 부작용을 최소화한 아세트아미노펜 조성물
KR20200119351A (ko) 수계 캡사이시노이드 제형 및 제조 방법 및 용도
KR20210118883A (ko) 레시니페라톡신을 투여하여 골관절염 통증을 치료하는 방법
JP2019506397A5 (enExample)
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
RU2181588C2 (ru) Способ профилактики отсроченной рвоты
US20250288591A1 (en) Trimeprazine for use in treating trigeminal neuralgia and for reducing pain related thereto
US20100016265A1 (en) Anti-inflammatory composition and method for preparation
RU2369393C2 (ru) Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна
CN104906501A (zh) 治疗银屑病的中药组分组合物
JPH061721A (ja) 疼痛処置剤、及び疼痛軽減作用増強剤
WO2000050028A1 (en) Compositions for the treatment of pain
CN1149986C (zh) 对乙酰氨基酚用于制造治疗与偏头痛相关的畏光症的药物的用途
JP2018531271A (ja) 静脈内バクロフェン及び治療方法
WO2024221023A1 (en) Anti-inflammatory, analgesic and antipyretic suppository
LU86004A1 (fr) Composition antalgique et anti-inflammatoire destinee au traitement de l'arthrose
O'Mathúna Prolotherapy for Chronic Musculoskeletal Pain
WO2016092377A2 (ru) Композиция, содержащая глюкозамин, фруктобарат кальция и витамин d для лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов, её применение и способ лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов и позвоночника

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110513

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140912

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151201

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160823

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151201

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160823

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20160401

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20140912

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20161219

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20161122

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160823

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160401

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20151201

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20140912